In vitro studies of the neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (Aβ1-42) toxicity and aggregation
Neurochemistry International; https://doi.org/10.1016/j.neuint.2019.01.010
Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice
Molecular and Cellular Neuroscience; https://doi.org/10.1016/j.mcn.2019.103390.
Marine bacterial extracts as a new rich source of drugs against Alzheimer’s disease.
Journal of Neurochemistry; https://doi.org/10.1111/jnc.14847.
Small molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer’s disease
bioRxiv; doi: https://doi.org/10.1101/729392.
17 Oxo Sparteine and Lupanine, Obtained from Cytisus scoparius, Exert a Neuroprotection against Soluble Oligomers of Amyloid-β Toxicity by Nicotinic Acetylcholine Receptors.
Journal of Alzheimer’s Disease; DOI: 10.3233/JAD-180945.
Amyloid-β/Drug Interactions from Computer Simulations and Cell-Based Assays
IOS Press; DOI 10.3233/JAD-179902.
Medical Plants and Nutraceuticals for Amyloid- Beta Fibrillation Inhibition
IOS Press; DOI 10.3233/ADR-180066.
Inflammation-induced Iron Transport and Metabolism by Brain Microglia.
JBC; DOI: 10.3233/JAD-170961.
Light-triggered dissociation of self-assembled β-amyloid aggregates into small, nontoxic fragments by ruthenium (II) complex.
Acta Biomaterialia; https://doi.org/10.1016/j.actbio.2017.11.048.
Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression
Acta Neuropathologica Communications; https://doi.org/10.1186/s40478-018-0529-x.